Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a ...

As big pharmas including Takeda and Novo Nordisk flee the cell therapy space and smaller biotechs shutter their operations, ...

In their new study, the LJI scientists are the first to show that GPR25 is induced by a signaling molecule called TGF-β.

By contrast, glial cells seemed to be electrically silent and were dismissed as dull by most researchers. Some glia, called ...

Progress in the treatment of T-cell blood cancers – which are rare – has also been modest. So, much remains to be done to ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...

A new type of cancer cell that "warrants urgent investigation" has been discovered in childhood leukemia and could impact clinical care. Research into new or repurposed treatments that target this new ...

Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral ...

Nkarta pivots its NK pipeline to autoimmune disease with NKX019 progress and strong cash runway supporting milestones into ...

Discover Boehringer Ingelheim’s pipeline focus areas and how its dealmaking in 2025 has expanded its therapeutic arsenal.

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...

KYV-101 demonstrated significant efficacy in reducing MG-ADL and QMG scores in gMG patients, with rapid and sustained effects ...